Con: Methylprednisolone is not indicated for patients during cardiopulmonary bypass

J Cardiothorac Vasc Anesth. 2005 Apr;19(2):255-8. doi: 10.1053/j.jvca.2005.02.008.
No abstract available

Publication types

  • Comment
  • Review

MeSH terms

  • Anti-Inflammatory Agents / adverse effects*
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use*
  • Cardiopulmonary Bypass*
  • Clinical Trials as Topic
  • Humans
  • Inflammation / physiopathology
  • Lung Diseases / chemically induced
  • Lung Diseases / pathology
  • Methylprednisolone / adverse effects*
  • Methylprednisolone / pharmacology
  • Methylprednisolone / therapeutic use*
  • Neuroprotective Agents / therapeutic use
  • Postoperative Complications / prevention & control

Substances

  • Anti-Inflammatory Agents
  • Neuroprotective Agents
  • Methylprednisolone